Axim Biotechnologies Inc lost $0.04 per diluted share in fiscal year 2023. That is unchanged from the prior fiscal year. Over the trailing 12 months, Q3 FY2023 through Q2 FY2024, the same line adds up to a loss of $0.02 per diluted share. The table below carries 13 fiscal years, from 2011 to 2023, and the quarters Axim Biotechnologies Inc has filed alongside them.
FY2023 annual
EPS (Diluted)-$0.04
YoY0.0%
Source SEC Filings (10-K/10-Q)Latest period Q2 FY2024, ended Jun 30, 2024ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
AXIM EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Axim Biotechnologies Inc's diluted earnings per share in fiscal year 2023?
Axim Biotechnologies Inc lost $0.04 per diluted share in fiscal year 2023.
How fast is Axim Biotechnologies Inc's diluted earnings per share growing?
Axim Biotechnologies Inc (AXIM) diluted earnings per share was essentially unchanged year over year, at -$0.04 in fiscal year 2023 against -$0.04 the year before.
What is Axim Biotechnologies Inc's diluted earnings per share over the last twelve months?
Axim Biotechnologies Inc (AXIM) reported a loss of $0.02 per diluted share over the trailing 12 months, Q3 FY2023 through Q2 FY2024, summed from the four most recent quarterly filings.
What was Axim Biotechnologies Inc's diluted earnings per share in the most recent quarter?
Axim Biotechnologies Inc (AXIM) reported -$0.01 in diluted earnings per share in Q2 2024. This represents an increase of 50.0% from the same quarter a year earlier.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Axim Biotechnologies Inc (AXIM) reported on that line in every period on record.
